Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis
NCT03967210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 132
Last updated 2021-08-23
Summary
Klebsiella pneumoniae is implicated in the occurrence of severe pneumonia. Most Klebsiella pneumoniae infections are associated with care and occur in patients with compromised immune defenses. More recently, cases of hepatic abscess and acute community meningitis related to strains of Klebsiella pneumoniae have been reported. The mortality of these infections is important, most often due to a delayed diagnosis. The poor prognostic factors reported in the literature for very low numbers are: advanced age, coma, septic shock, glyceryachia \<10mg / dL and proteinuria\> 750 mg / dL. In addition, no study has specifically focused on the factors of occurrence and factors associated with Klebsiella sp. Indeed, meningitis related to Klebsiella pneumoniae seems to be a rare but probably underestimated event whose risk factors, clinical presentation, microbiological are little known and the treatment modalities of this severe infection are not codified.
Conditions
Sponsors & Collaborators
-
Fondation Hôpital Saint-Joseph
lead OTHER
Principal Investigators
-
Benoit PILMIS, MD · Fondation Hôpital Saint-Joseph
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-07-05
- Primary Completion
- 2019-12-31
- Completion
- 2020-01-13
Countries
- France
Study Locations
More Related Trials
-
Clinical Outcomes of Hypervirulent Carbapenem-resistant Klebsiella Pneumoniae Infection
NCT06190548 ·Status: COMPLETED
-
Pharmacological Study of High Doses of Ceftriaxone in Meningitidis
NCT01745679 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis on the Infection Risk, Prognosis, and Drug Sensitivity of Klebsiella Pneumoniae.
NCT04337840 ·Status: UNKNOWN
-
Epidemiological Characteristics and Treatment Protocol for Carbapenem-Resistant Klebsiella Pneumoniae in China
NCT03245632 ·Status: UNKNOWN
-
Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD).
NCT03481569 ·Status: COMPLETED ·Phase: PHASE1
-
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
NCT03767283 ·Status: UNKNOWN
-
Linezolid-resistant Staphylococcus Epidermidis in ICU and Risk Factors Analysis
NCT03140410 ·Status: UNKNOWN
-
Microbiology Studies of Acute Head and Neck Infections
NCT05874908 ·Status: ENROLLING_BY_INVITATION
-
Impact of Cefotaxime and Ceftriaxone on the Emergence and Carrying of Multidrug-Resistant Bacteria
NCT03903783 ·Status: COMPLETED ·Phase: NA
-
Double Carbapenem as Rescue Strategy for the Treatment of Carbapenemase-Producing Klebsiella Pneumoniae Infections
NCT03094494 ·Status: COMPLETED
-
Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus Pneumoniae
NCT02583373 ·Status: COMPLETED ·Phase: PHASE1
-
Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration
NCT00752882 ·Status: UNKNOWN ·Phase: PHASE2
-
Detection of Colistin-resistant Isolates From Patients of Intensive Care Units and Oncohaematology Wards.
NCT03971877 ·Status: COMPLETED
-
Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
NCT00300560 ·Status: UNKNOWN ·Phase: PHASE3
-
Resistant Bacteria in Children in France
NCT06036628 ·Status: COMPLETED
-
Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli
NCT02474706 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety Study of Short-term Antibiotic for Pyelonephritis in Women
NCT01390623 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Linezolid and Vancomycin on Inflammation and Cellular Signaling Vents
NCT00811980 ·Status: COMPLETED
-
Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
NCT07013864 ·Status: COMPLETED
-
Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital
NCT05862402 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections
NCT04625478 ·Status: COMPLETED
-
Description of Lung Transplant Patients With Microbiologically Documented Stenotrophomonas Maltophilia Pneumonia and Impact of Treatment on Outcome
NCT05193058 ·Status: UNKNOWN
-
Using Microbial Genomics to Elucidate the Source of Central-line Associated Bloodstream Infections
NCT02271243 ·Status: RECRUITING
-
Clinical Impact of Rapid AST Directly From Blood Cultures
NCT03992703 ·Status: COMPLETED
-
Multicenter Evaluation of the Susceptibility of Enterobacteriaceae and Pseudomonas Aeruginosa to Ceftolozane/Tazobactam Combination
NCT03963297 ·Status: COMPLETED